BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7684498)

  • 1. The tumor suppressor p53 regulates its own transcription.
    Deffie A; Wu H; Reinke V; Lozano G
    Mol Cell Biol; 1993 Jun; 13(6):3415-23. PubMed ID: 7684498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site.
    Kanda T; Segawa K; Ohuchi N; Mori S; Ito Y
    Mol Cell Biol; 1994 Apr; 14(4):2651-63. PubMed ID: 8139565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
    Furlong EE; Rein T; Martin F
    Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
    Aoyama N; Nagase T; Sawazaki T; Mizuguchi G; Nakagoshi H; Fujisawa JI; Yoshida M; Ishii S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5403-7. PubMed ID: 1535157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of Rb expression by the p53 gene product.
    Shiio Y; Yamamoto T; Yamaguchi N
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain.
    Quitschke WW; Goldgaber D
    J Biol Chem; 1992 Aug; 267(24):17362-8. PubMed ID: 1380960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of p53 on the promoters of mouse DNA polymerase beta gene and proliferating-cell-nuclear-antigen gene.
    Yamaguchi M; Hayashi Y; Matsuoka S; Takahashi T; Matsukage A
    Eur J Biochem; 1994 Apr; 221(1):227-37. PubMed ID: 7909518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter.
    Shivakumar CV; Brown DR; Deb S; Deb SP
    Mol Cell Biol; 1995 Dec; 15(12):6785-93. PubMed ID: 8524244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
    Osifchin NE; Jiang D; Ohtani-Fujita N; Fujita T; Carroza M; Kim SJ; Sakai T; Robbins PD
    J Biol Chem; 1994 Mar; 269(9):6383-9. PubMed ID: 8119988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a minimal promoter element required for transcription of the mouse type II beta regulatory subunit (RII beta) of cAMP-dependent protein kinase.
    Luo Z; Singh IS; Fujihira T; Erlichman J
    J Biol Chem; 1992 Dec; 267(34):24738-47. PubMed ID: 1332964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
    Vikhanskaia FL; Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Poslepov VA
    Dokl Akad Nauk SSSR; 1991; 321(4):846-9. PubMed ID: 1806357
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
    Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
    Saifudeen Z; Du H; Dipp S; El-Dahr SS
    J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Miyashita T; Reed JC
    Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
    Pastorcic M; Das HK
    J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
    Lee KI; Reddy EP; Reddy CD
    J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the junB gene by v-src.
    Apel I; Yu CL; Wang T; Dobry C; Van Antwerp ME; Jove R; Prochownik EV
    Mol Cell Biol; 1992 Aug; 12(8):3356-64. PubMed ID: 1630451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.